tiprankstipranks
Trending News
More News >
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
Sweden Market

ExpreS2ion Biotech Holding AB (EXPRS2) Income Statement

Compare
0 Followers

ExpreS2ion Biotech Holding AB Income Statement

Last quarter (Q4 2024), ExpreS2ion Biotech Holding AB's total revenue was kr599.00K, a decrease of -45.99% from the same quarter last year. In Q4, ExpreS2ion Biotech Holding AB's net income was kr-15.64M. See ExpreS2ion Biotech Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 3.01Mkr 7.05Mkr 5.09Mkr 12.23Mkr 5.26M
Gross Profit
kr -2.67Mkr 3.40Mkr 5.00Kkr 4.72Mkr -843.00K
Operating Expenses
kr 65.03Mkr 106.53Mkr 127.61Mkr 53.12Mkr 30.35M
Depreciation and Amortization
kr 1.64Mkr 1.60Mkr 1.22Mkr 1.81Mkr 2.92M
EBITDA
kr -42.20Mkr -102.45Mkr -124.49Mkr -46.38Mkr -28.47M
Operating Income
kr -67.69Mkr -105.97Mkr -127.61Mkr -48.40Mkr -31.20M
Other Income/Expenses
kr 23.13Mkr 6.00Mkr 1.02Mkr 880.00Kkr -3.73M
Pretax Income
kr -44.56Mkr -99.97Mkr -126.58Mkr -47.52Mkr -34.92M
Net Income
kr -36.41Mkr -91.40Mkr -118.61Mkr -43.92Mkr -31.71M
Per Share Metrics
Basic EPS
kr -21.54kr -79.20kr -125.60kr -54.40kr -66.40
Diluted EPS
kr -14.02kr -79.20kr -125.60kr -54.40kr -66.40
Weighted Average Shares Outstanding
1.69M----
Weighted Average Shares Outstanding (Diluted)
2.60M----
Currency in SEK

ExpreS2ion Biotech Holding AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis